This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
Patient Care and General Interest
A father got a sternotomy scar tattoo in support of his son after the boy underwent surgery for supravalvular aortic stenosis.
In a Viewpoint paper in JAMA Surgery, the authors highlight the importance of training on Geneva conventions and humanitarian law for surgeons embarking on medical missions to conflict zones.
Drugs and Devices
The US Food and Drug Administration has cleared Mimics Enlight from Materialise, software that is intended to assist in planning complex transcatheter mitral valve replacement procedures.
Research, Trials, and Funding
Researchers from Vancouver, Canada, used gut bacteria to convert type A blood cells into type O.
Researchers from France find that spin in health news, defined as overstating the efficacy or safety of a treatment, positively influences people’s views of those treatments.
A restrictive approach to blood cell transfusions did not increase the risk of acute kidney injury in patients undergoing cardiac surgery on cardiopulmonary bypass, report researchers from London, Canada.
US News & World Report published a list of 613 hospitals in Cardiology & Heart Surgery that see many challenging patients, including those needing heart transplants, those with cardiovascular disease, and other complex heart conditions. In order to be eligible for ranking, listed hospitals had to treat at least 1,391 such Medicare inpatients in 2014, 2015, and 2016. The 50 top-scoring hospitals are ranked, followed by high performing hospitals.
This position paper written by the EACTS, STS, and AATS Valve Labeling Task Force focuses on problems around sizing and labeling of various prosthetic valves. The authors provide information on European and international regulations and use of standards in prosthetic heart valve labeling, characteristics of surgical prosthetic heart valve design, and their hemodynamic performance and thrombogenicity. This first paper from the task force reviews current practices and identifies where improvements are necessary.
This large review of over 100,000 patients undergoing transcatheter aortic valve replacement demonstrated a stroke rate of 2.3% within 30 days of the procedure, and no decrease in the rate between 2011 and 2015.
Thoracoabdominal aortic aneurysm (TAAA) repair began in Houston, Texas, with pioneer surgeons such as Drs Michael E. DeBakey, Denton A. Cooley, and E. Stanley Crawford. Their early attempts to repair TAAA were complicated by risk of renal and spinal cord ischemia and difficulty in reattaching the branching vessels of the thoracoabdominal aorta. This article delves into this history and the work being done at the current forefront of TAAA repair.
To evaluate the benefit of multimodality treatment for patients with limited disease small-cell lung cancer, Weckler and colleagues retrospectively reviewed outcomes for 47 patients treated at their institution between 1999 and 2016. Patients had undergone primary tumor resection and systematic lymph node dissection combined with chemotherapy, chemoradiotherapy, or thoracic radiotherapy, and all patients were treated with curative intent. Overall median survival was 56 months, and R0 resection was the only significant prognostic factor for survival. The authors conclude that multimodality treatment was safe, and that R0 resection was achievable with a low risk of locoregional relapse.
An intresting pilot that was stopped due to underrecruitment. Commendable mortality in high-risk coronary artery bypass grafting.
Food for thought from a retrospective non-randomized study on the Scandinavian experience with acute aortic dissection. The reader may find outcomes that will surpise them.
In this retrospective review of the effects of radiation dose to the heart on long-term outcomes, 748 patients with regionally advanced non–small cell lung cancer were studied. An increasing cardiac radiotherapy dose was associated with an increased risk of MACE and all-cause mortality. This was observed primarily in patients without preexisting heart disease.